Literature DB >> 19379639

Therapy for acute heart failure syndromes.

Sarah M Donlan1, Erin Quattromani, Peter S Pang, Mihai Gheorghiade.   

Abstract

The pharmacologic management of acute heart failure syndromes (AHFS) has changed little over the past 15 years. Traditional therapies, such as nitrates and loop diuretics, remain the mainstay of therapy, with inotropes reserved for patients who present in shock or an advanced low-output state. We review the use of these therapies in AHFS with added insights from recent clinical trials and registry data.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19379639     DOI： 10.1007/s11886-009-0028-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  42 in total

1.  Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States.

Authors:  J L Anderson
Journal:  Am Heart J       Date:  1991-06       Impact factor: 4.749

Review 2.  Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute heart failure syndromes.

Authors:  Scott M Silvers; John M Howell; Joshua M Kosowsky; Ivan C Rokos; Andy S Jagoda
Journal:  Ann Emerg Med       Date:  2007-04-03       Impact factor: 5.721

3.  Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.

Authors:  Andrew J Burger; Darlene P Horton; Thierry LeJemtel; Jalal K Ghali; Guillermo Torre; George Dennish; Michael Koren; Jay Dinerman; Marc Silver; Mei L Cheng; Uri Elkayam
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

4.  Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.

Authors:  M H Yamani; S A Haji; R C Starling; L Kelly; N Albert; D L Knack; J B Young
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

5.  Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema.

Authors:  J R Hoffman; S Reynolds
Journal:  Chest       Date:  1987-10       Impact factor: 9.410

Review 6.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

7.  Sodium nitroprusside for advanced low-output heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; Hadi N Skouri; Randall C Starling; James B Young; David O Taylor; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

8.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction.

Authors:  A Sigurdsson; K Swedberg
Journal:  Eur Heart J       Date:  1994-05       Impact factor: 29.983

10.  Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.

Authors:  A Elis; T Bental; O Kimchi; M Ravid; M Lishner
Journal:  Clin Pharmacol Ther       Date:  1998-06       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.